Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 


COX inhibitor
BML-EI358-0005 5 mg 132.00 USD
BML-EI358-0025 25 mg 468.00 USD
Do you need bulk/larger quantities?
DuP-697 is a highly selective and irreversible inhibitor of cyclooxygenase-2 (COX-2). (COX-2 IC50=10nM, COX-1 IC50=800nM). It is an orally effective anti-inflammatory, analgesic and antipyretic agent which is not ulcerogenic. Inhibition of COX-2 by DuP-697 and other inhibitors exacerbates ischemia-induced myocardial dysfunction in the rabbit. It inhibits angiogenesis and induces apoptosis in human endothelial cells.

Product Specification

Alternative Name:(5-Bromo-2[4-fluorophenyl]-3-[4-methylsulfonyl-phenyl]thiophene)
Purity:≥98% (TLC)
Identity:Determined by NMR.
Appearance:White to off-white solid.
Solubility:Soluble in DMSO (10mg/ml) or 100% ethanol (5mg/ml).
Long Term Storage:-20°C
Please mouse over

Product Literature References

Inhibition of angiogenic tubule formation and induction of apoptosis in human endothelial cells by the selective cyclooxygenase-2 inhibitor 5-bromo-2-(4-fluorophenyl)-3-(methylsulfonyl) thiophene (DuP-697): A. Churchman, et al.; Eur. J. Pharmacol. 573, 176 (2007), Abstract;
Inhibition of cyclo-oxygenase-2 exacerbates ischaemia-induced acute myocardial dysfunction in the rabbit: G. Rossoni, et al.; Br. J. Pharmacol. 135, 1540 (2002), Abstract;
Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase: R.A. Copeland, et al.; PNAS USA 91, 11202 (1994), Abstract;
Anti-inflammatory and safety profile of DuP 697, a novel orally effective prostaglandin synthesis inhibitor: K.R. Gans, et al.; J. Pharmacol. Exp. Ther. 254, 180 (1990), Abstract;

Related Literature

Integrated solutions for screening Wnt regulators
Integrated solutions for screening Wnt regulators
Download as PDF

All new literature pieces

Recommend this page

For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2019 Enzo Life Sciences, Inc.,